Guidelines for diagnosis and treatment of Hunter Syndrome for clinicians in Latin America-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Guidelines for diagnosis and treatment of Hunter Syndrome for clinicians in Latin America

Published:2014-06 Issue:2 Volume:37 Page:315-329
ISSN:1415-4757
Container-title:Genetics and Molecular Biology
language:
Short-container-title:Genet. Mol. Biol.

Author:

Giugliani Roberto¹,Villarreal Martha Luz Solano²,Valdez C. Araceli Arellano³,Hawilou Antonieta Mahfoud⁴,Guelbert Norberto⁵,Garzón Luz Norela Correa⁶,Martins Ana Maria⁷,Acosta Angelina⁸,Cabello Juan Francisco⁹,Lemes Aída¹⁰,Santos Mara Lucia Schmitz Ferreira¹¹,Amartino Hernán¹²

Affiliation:

1. Hospital de Clinicas de Porto Alegre, Brazil; Universidade Federal do Rio Grande do Sul, Brasil; Instituto Nacional de Genética Médica Populacional, Brazil

2. Asociación Colombiana de Neurología Infantil, Colombia

3. Instituto Mexicano del Seguro Social, Mexico

4. Instituto de Estudios Avanzados

5. Hospital de Niños, Argentina

6. La Misericordia University Hospital, Colombia

7. Universidade Federal de São Paulo, Brazil

8. Universidade Federal de Bahia

9. Universidad de Chile, Chile

10. Hospital Italiano, Uruguay

11. Hospital Pequeno Príncipe, Brazil

12. Hospital Universitario Austral, Argentina

Publisher

FapUNIFESP (SciELO)

Subject

Genetics,Molecular Biology

Link

http://www.scielo.br/pdf/gmb/v37n2/a03v37n2.pdf

Reference53 articles.

1. First experience of enzyme replacement therapy with idursulfase in Spanish patients with Hunter syndrome under 5 years of age: Case observations from the Hunter Outcome Survey (HOS);Alcalde-Martin C;Eur J Med Genet,2010

2. ATS statement: guidelines for the six-minute walk test;Am J Respir Crit Care Med,2002

3. Lysosomal disorders: from storage to cellular damage;Ballabio A;Biochim Biophys Acta,2009

4. The relationship between anti-idursulfase antibody status and safety and efficacy outcomes in attenuated mucopolysaccharidosis II patients aged 5 years and older treated with intravenous idursulfase;Barbier AJ;Mol Genet Metab,2013

5. Mucopolysaccharidosis type II (Hunter syndrome): clinical picture and treatment;Beck M;Curr Pharm Biotechnol,2011

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Disease features and management of cardiomyopathies in women;Heart Failure Reviews;2024-02-03

2. Salivary Metabolites in Patients with Mucopolysaccharidosis;Pesquisa Brasileira em Odontopediatria e Clínica Integrada;2024

3. Mucopolysaccharidosis type II (Hunter syndrome) in a boy from the Republic of Serbia: A case report;Kragujevac Journal of Science;2023

4. A Retrospective Study of Mucopolysaccharidosis Type II in Brazil - Data from Brazilian Health System (DATASUS);Journal of Inborn Errors of Metabolism and Screening;2023

5. First-in-human in vivo genome editing via AAV-zinc-finger nucleases for mucopolysaccharidosis I/II and hemophilia B;Molecular Therapy;2022-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3